Viewing Study NCT01635803


Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2025-12-31 @ 12:08 AM
Study NCT ID: NCT01635803
Status: UNKNOWN
Last Update Posted: 2015-07-01
First Post: 2012-06-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module